These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5038101)

  • 41. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serologic specificity of the positive direct antiglobulin test in ABO heterospecific pregnancies.
    Alter AA; Prutting DL; Hertz S; Bryan DE
    Obstet Gynecol; 1969 Jul; 34(1):102-5. PubMed ID: 5306024
    [No Abstract]   [Full Text] [Related]  

  • 43. [Serological conflict].
    Marianowski L
    Pieleg Polozna; 1982; (1-2):4-5, 15. PubMed ID: 6808531
    [No Abstract]   [Full Text] [Related]  

  • 44. [Neonatal hemolytic disease. II. Diagnostic, prognostic and therapeutic considerations on 24 cases of neonatal hemolytic disease caused by ABO factor isoimmunization].
    Saggese V; Di Marco A; Polito P
    Riv Clin Pediatr; 1967 Jan; 79(1):23-32. PubMed ID: 5628068
    [No Abstract]   [Full Text] [Related]  

  • 45. Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG Antibody Subclasses in Hemolytic Disease of Newborn.
    Wu Q; Zhang Y; Liu M; Wang B; Liu S; He C
    Neonatology; 2009; 96(1):1-5. PubMed ID: 19129718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Our experience in the diagnosis and clinical course of hemolytic disease of the newborn].
    Novachev D
    Akush Ginekol (Sofiia); 1967; 6(1):15-21. PubMed ID: 5601850
    [No Abstract]   [Full Text] [Related]  

  • 47. Complement is not activated in AB0-hemolytic disease of the newborn: further support.
    Carreras Vescio LA; Castro RA
    Vox Sang; 1990; 58(3):231. PubMed ID: 2339535
    [No Abstract]   [Full Text] [Related]  

  • 48. Phagocytosis and erythroblastosis. I. Modification of the neonatal response by promethazine hydrochloride.
    Gusdon JP; Caudle MR; Herbst GA; Iannuzzi NP
    Am J Obstet Gynecol; 1976 May; 125(2):224-6. PubMed ID: 944534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Behavior of erythrocytic acetylcholinesterase activity in the hemolytic disease of the newborn due to ABO incompatibility in relation to erythrocyte age].
    Gerlini G; Ottaviano S; Sbraccia C; Carapella E; Bonanni V
    Riv Clin Pediatr; 1968; 81(5):742-5. PubMed ID: 5754265
    [No Abstract]   [Full Text] [Related]  

  • 50. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 51. Quantity of hemolytic anti-A and anti-B in individuals of a human population: correlations with isoagglutinins and effects of the individual's age and sex.
    Grundbacher FJ
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):317-49. PubMed ID: 4233546
    [No Abstract]   [Full Text] [Related]  

  • 52. Red cell-bound complement associated with ABO-hemolytic disease of the newborn.
    Garratty G
    Vox Sang; 1992; 63(3):240. PubMed ID: 1448972
    [No Abstract]   [Full Text] [Related]  

  • 53. ABO hemolytic disease caused by a cross-reacting antibody. Report of a case.
    Hughes BE
    Am J Clin Pathol; 1965 Dec; 44(6):665-6. PubMed ID: 5891841
    [No Abstract]   [Full Text] [Related]  

  • 54. Diagnosis and treatment of the immune hemolytic anemias.
    Rosenfield RE; Diamond SH
    Haematologia (Budap); 1981; 14(3):247-56. PubMed ID: 7035308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood group distribution and ABO haemolytic disease of the newborn in Jamaica.
    Lindo-Haynes G
    Med Lab Sci; 1980 Jun; 37(3):263-6. PubMed ID: 6783806
    [No Abstract]   [Full Text] [Related]  

  • 56. Some observations on the ABO antigen sites of the erythrocyte membranes of adults and newborn infants.
    Haberman S; Blanton P; Martin J
    J Immunol; 1967 Jan; 98(1):150-60. PubMed ID: 4163637
    [No Abstract]   [Full Text] [Related]  

  • 57. [Obstetrical problems in hemolytic disease of the newborn].
    Pontuch A
    Cesk Gynekol; 1969 Oct; 34(8):457-62. PubMed ID: 5354327
    [No Abstract]   [Full Text] [Related]  

  • 58. ABO haemolytic disease of the newborn.
    Graham H; Kenwright M
    Nurs Mirror Midwives J; 1977 Mar; 144(13):48-50. PubMed ID: 585058
    [No Abstract]   [Full Text] [Related]  

  • 59. [Value of the Ducos-Ohayon-Marty-Bierme test in the serologic diagnosis of neonatal hemolytic disease due to ABO incompatibility].
    Streiff F; Genetet B; Raffoux C; Landes P; Brunel G; Richon J
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):487-91. PubMed ID: 5153257
    [No Abstract]   [Full Text] [Related]  

  • 60. Serum complement in the newborn. An investigation of complement activity in normal infants and in Rh and AB hemolytic disease.
    EWALD RA; WILLIAMS JH; BOWDEN DH
    Vox Sang; 1961 May; 6():312-9. PubMed ID: 13697676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.